Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02688647 |
|---|---|
| Brief Title: | A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis |
| First Submitted : | February 18, 2016 |
| First Submitted that Met QC Criteria : | February 22, 2016 |
| First Posted : | February 23, 2016 (Estimate) |
| Results First Submitted : | April 13, 2022 |
| Results First Submitted that Met QC Criteria : | September 6, 2022 |
| Results First Posted : | September 8, 2022 |
| Last Update Submitted that Met QC Criteria : | September 6, 2022 |
| Last Update Posted : | September 8, 2022 |